Key result
Pharmacist involvement in primary care significantly reduced systolic (p=0.037) and diastolic (p=0.027) blood pressure compared to no pharmacist involvement over 6 months.
Why the study?
Does pharmacist involvement reduce blood pressure and improve adherence in hypertensive patients in primary care settings?
Population
235 hypertensive patients in primary care settings in Thailand
Comparison
Pharmacist involvement including monthly… vs No pharmacist involvement (control group)
Design
RCT, randomly assigned
Follow-up
6 months
Authors
Loading...
May support pharmacist integration in primary care hypertension teams; hypothesis-generating for adherence and long-term outcomes.
RCT (n=235)
Randomized
Yes
Does pharmacist involvement reduce blood pressure and improve adherence in hypertensive patients in primary care settings?
p-value: p=0.037 (SBP), 0.027 (DBP)
Sookaneknun et al. (2004) conducted an RCT in Hypertension (n=235). Pharmacist involvement (monthly medication review, pharmaceutical care, and counseling) vs. No pharmacist involvement was evaluated on Reduction in systolic and diastolic blood pressure (p=0.037 (SBP), 0.027 (DBP)). Pharmacist involvement in primary care significantly reduced systolic (p=0.037) and diastolic (p=0.027) blood pressure compared to no pharmacist involvement over 6 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: